Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 6 | 2024 | 497 | 1.090 |
Why?
|
| Hepatitis C Antibodies | 2 | 2024 | 27 | 0.850 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2024 | 259 | 0.820 |
Why?
|
| Hepacivirus | 3 | 2024 | 274 | 0.790 |
Why?
|
| Hepatitis C | 2 | 2024 | 390 | 0.780 |
Why?
|
| Pregnancy | 15 | 2024 | 7402 | 0.330 |
Why?
|
| Pregnancy Outcome | 4 | 2024 | 617 | 0.240 |
Why?
|
| Hospitalization | 2 | 2024 | 1928 | 0.230 |
Why?
|
| Hepatitis E | 1 | 2024 | 7 | 0.220 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2023 | 19 | 0.200 |
Why?
|
| RNA, Viral | 1 | 2024 | 502 | 0.180 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 419 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 165 | 0.160 |
Why?
|
| Coronavirus | 1 | 2020 | 27 | 0.160 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 224 | 0.160 |
Why?
|
| Risk Factors | 3 | 2024 | 10978 | 0.150 |
Why?
|
| Cesarean Section | 2 | 2015 | 426 | 0.150 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 540 | 0.140 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2016 | 4 | 0.120 |
Why?
|
| Female | 15 | 2024 | 70550 | 0.120 |
Why?
|
| Hypertension | 1 | 2024 | 1354 | 0.120 |
Why?
|
| Feeding Methods | 1 | 2015 | 35 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2022 | 5095 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2024 | 8509 | 0.110 |
Why?
|
| Adult | 10 | 2024 | 31238 | 0.100 |
Why?
|
| Zika Virus Infection | 1 | 2016 | 170 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2015 | 232 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2015 | 297 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 912 | 0.100 |
Why?
|
| Microcephaly | 1 | 2016 | 347 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1158 | 0.090 |
Why?
|
| Humans | 15 | 2024 | 130854 | 0.080 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2024 | 110 | 0.080 |
Why?
|
| Length of Stay | 1 | 2015 | 1396 | 0.080 |
Why?
|
| Endometritis | 1 | 2008 | 9 | 0.070 |
Why?
|
| Young Adult | 4 | 2024 | 10040 | 0.070 |
Why?
|
| Labor Stage, First | 1 | 2007 | 8 | 0.070 |
Why?
|
| Premature Birth | 2 | 2024 | 421 | 0.070 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2008 | 114 | 0.070 |
Why?
|
| Obstetric Labor, Premature | 1 | 2007 | 76 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17673 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2008 | 359 | 0.060 |
Why?
|
| Hepatitis E virus | 1 | 2024 | 5 | 0.050 |
Why?
|
| United States | 3 | 2024 | 11865 | 0.050 |
Why?
|
| Stillbirth | 1 | 2024 | 105 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 20818 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 217 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2024 | 1343 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 316 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2694 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 1997 | 44 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 1996 | 110 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 1997 | 185 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 2303 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1996 | 94 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 3130 | 0.030 |
Why?
|
| Candidiasis | 1 | 1997 | 133 | 0.030 |
Why?
|
| Nausea | 1 | 2015 | 83 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 28511 | 0.030 |
Why?
|
| Vomiting | 1 | 2015 | 101 | 0.030 |
Why?
|
| Estradiol | 1 | 1996 | 470 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2015 | 143 | 0.030 |
Why?
|
| Zika Virus | 1 | 2016 | 149 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 291 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1082 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3400 | 0.020 |
Why?
|
| Echocardiography | 1 | 1997 | 1127 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6448 | 0.020 |
Why?
|
| Tocolysis | 1 | 2007 | 5 | 0.020 |
Why?
|
| Tocolytic Agents | 1 | 2007 | 11 | 0.020 |
Why?
|
| Texas | 1 | 2015 | 3635 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 426 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 265 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20970 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6217 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2007 | 255 | 0.010 |
Why?
|
| Sepsis | 1 | 2008 | 497 | 0.010 |
Why?
|
| Child | 1 | 2024 | 26215 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1269 | 0.010 |
Why?
|
| Male | 1 | 2024 | 64763 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1996 | 152 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 812 | 0.010 |
Why?
|
| Tamoxifen | 1 | 1996 | 349 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1997 | 1457 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1618 | 0.010 |
Why?
|